85 related articles for article (PubMed ID: 21651353)
1. The role of hepatocyte-specific staining in liver pathology.
Filippone A; Cianci R; Patriarca G; Sabatino F; Tartaro A; Cotroneo AR
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):353-63. PubMed ID: 21651353
[TBL] [Abstract][Full Text] [Related]
2. MR imaging of the liver. Contrast agents.
Mahfouz AE; Hamm B
Magn Reson Imaging Clin N Am; 1997 May; 5(2):223-40. PubMed ID: 9113673
[TBL] [Abstract][Full Text] [Related]
3. Diffusion and perfusion imaging of the liver.
Chandarana H; Taouli B
Eur J Radiol; 2010 Dec; 76(3):348-58. PubMed ID: 20399054
[TBL] [Abstract][Full Text] [Related]
4. Contrast agents for MR imaging of the liver.
Balci NC; Semelka RC
Radiol Clin North Am; 2005 Sep; 43(5):887-98, viii. PubMed ID: 16098345
[TBL] [Abstract][Full Text] [Related]
5. Focal liver lesion detection and characterization with GD-EOB-DTPA.
Purysko AS; Remer EM; Veniero JC
Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of the liver.
Larson RE; Semelka RC
Top Magn Reson Imaging; 1995; 7(2):71-81. PubMed ID: 7772372
[TBL] [Abstract][Full Text] [Related]
7. [Progress in magnetic resonance tomography of the liver: value of ultra-rapid imaging and liver-specific contrast media].
Reimer P; Rummeny EJ; Hamm B; Mühler A; Cavagna F; Saini S; Peters PE
Bildgebung; 1994 Mar; 61(1):5-13. PubMed ID: 8193519
[TBL] [Abstract][Full Text] [Related]
8. In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes.
Ketkar-Atre A; Struys T; Dresselaers T; Hodenius M; Mannaerts I; Ni Y; Lambrichts I; Van Grunsven LA; De Cuyper M; Himmelreich U
Biomaterials; 2014 Jan; 35(3):1015-24. PubMed ID: 24210051
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
Chou CT; Chen YL; Su WW; Wu HK; Chen RC
J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
[TBL] [Abstract][Full Text] [Related]
10. [Iron oxides as contrast agents for MRI of the liver].
Van Beers BE; Pringot J; Gallez B
J Radiol; 1995 Nov; 76(11):991-5. PubMed ID: 8594187
[TBL] [Abstract][Full Text] [Related]
11. [VIBE with parallel acquisition technique - a novel approach to dynamic contrast-enhanced MR imaging of the liver].
Dobritz M; Radkow T; Nittka M; Bautz W; Fellner FA
Rofo; 2002 Jun; 174(6):738-41. PubMed ID: 12063604
[TBL] [Abstract][Full Text] [Related]
12. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver.
Low RN
Top Magn Reson Imaging; 1998 Jun; 9(3):141-66. PubMed ID: 9621404
[TBL] [Abstract][Full Text] [Related]
13. [Value of MRI in diagnosis of focal liver lesions].
Taupitz M; Hamm B
Radiologe; 1995 Nov; 35(11 Suppl 2):S243-7. PubMed ID: 8588028
[No Abstract] [Full Text] [Related]
14. [The value of breath-hold diffusion-weighted imaging in small hepatocellular carcinoma lesion (Xu PJ; Yan FH; Wang JH; Lin J; Ji Y; Chen CZ; Shen JZ; Li RC
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(9):592-6. PubMed ID: 19595157
[TBL] [Abstract][Full Text] [Related]
15. Characterization of hyperintense nodules on precontrast T1-weighted MRI: utility of gadoxetic acid-enhanced hepatocyte-phase imaging.
Chou CT; Chen YL; Wu HK; Chen RC
J Magn Reson Imaging; 2011 Mar; 33(3):625-32. PubMed ID: 21563246
[TBL] [Abstract][Full Text] [Related]
16. [The value of magnetic resonance tomography in the detection and differential diagnosis of focal liver lesions].
Hamm B
Radiologe; 1992 May; 32(5):232-40. PubMed ID: 1635983
[TBL] [Abstract][Full Text] [Related]
17. Contrast media safety-an update.
Thomsen HS
Eur J Radiol; 2011 Oct; 80(1):77-82. PubMed ID: 21856102
[TBL] [Abstract][Full Text] [Related]
18. Special issue: nephrogenic systemic fibrosis.
Leiner T; Kucharczyk W
J Magn Reson Imaging; 2009 Dec; 30(6):1233-5. PubMed ID: 19938034
[No Abstract] [Full Text] [Related]
19. Liver MRI with contrast enhancement.
Runge VM
Crit Rev Diagn Imaging; 1997 Jun; 38(3):207-30. PubMed ID: 9226107
[TBL] [Abstract][Full Text] [Related]
20. MRI contrast media: what clinicians need to know.
Das CJ; Mahalingam S; Debnath J; Dhawan S
Natl Med J India; 2010; 23(5):292-6. PubMed ID: 21250587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
